4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-11-000428
PRES./CHIEF SCIENTIFIC OFFICER acquired 545,416 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award | +545,416 | $3.50 | $1,908,956 | 545,416 | D |
| Derivatives | |||||||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +56,818 | 56,818 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +3,181 | 3,181 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-05-11 | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
Loading xslF345X03/form4-05252011_030541.xml…